Name: Global Therapeutic Radiopharmaceuticals Market Insights, Forecast to 2035
Brand: Extent Research
Price: 3500 USD
Availability: InStock
Rating: 5.0 (131 reviews)

Global Therapeutic Radiopharmaceuticals Market

Market Size in USD Billion

CAGR : 17.60%

USD 1.14

2025

USD 4.17

2033

Forecast Period	2025 - 2033
Market Size (Base Year)	USD 1.14 Billion
Market Size (Forecast)	USD 4.17 Billion
CAGR	17.60%
Major Market Players	Data provided in full report

EXTENT RESEARCH offers authentic industry insights and comprehensive information-loaded market reports to all the pre-established companies and startups. The market research experts available at EXTENT RESEARCH guide their clients to strategize corporate policies, which would help them accomplish sustainable growth in their respective sectors. The staff at the organization including data collection, research, publishing, and consulting teams work in collaboration to offer hassle-free services to the clients. The global Therapeutic Radiopharmaceuticals Market report illustrates the key emphasis such as strategies, business forecast, future predictions, consumer surveys, and opportunity analysis, among others.

Data provided by Extent Research. Source: https://www.extentresearch.com/therapeutic-radiopharmaceuticals-market

Crucial Pieces Of Information Inculcated In The Global Therapeutic Radiopharmaceuticals Market Report:

Global Therapeutic Radiopharmaceuticals market capitalization, size, CAGR, revenue generation, profits or losses incurred, manufacturing capability, and sales.
Global Therapeutic Radiopharmaceuticals market size evaluation based on the plausible segments Product type Radium-223, Lutetium-177, Iodine-131, Other, by Application Thyroid, Bone Metastasis, Lymphoma, Other, .
Summarized data of qualitative and quantitative research conducted on the multifarious industries belong to the Therapeutic Radiopharmaceuticals sector.
Size, share, and important fiscal information of the individual key contenders Bayer, Novartis, China Isotope & Radiation, Dongcheng, Q BioMed, Curium Pharmaceuticals, Jubilant DraxImage, Lantheus, Spectrum Pharmaceuticals, Progenics Pharmaceuticals, International Isotopes, driving the global Therapeutic Radiopharmaceuticals market.
Potential business-related threats for the novice or startups owing to the overdominance of the full-fledged industries.
Offers key information related to supply chain management, precise futuristic predictions, multifarious strategies to impel productivity & demand, current & forthcoming trends in the Therapeutic Radiopharmaceuticals business, and product evaluation.
The global Therapeutic Radiopharmaceuticals report depicts the key growth and restraints that fluctuate the performance of the industries.
The report highlights sensible reasons why a specific region is overshadowing in terms of production, sales, and revenue generation.
Impact of COVID-19 along with some robust strategies that industries can implement to mitigate the long-term effects of the pandemic.

In case of any doubts or queries, please feel free to contact our team by clicking on the link and schedule an appointment with one of our experts.

Report Scope and Market Segmentation

ATTRIBUTES	Global Therapeutic Radiopharmaceuticals Market KEY MARKET INSIGHTS
Segments Covered	By Product Type: All Products Type Includes By Application: All Application Type Includes By End User: All End User Type Includes By Distribution Channel: All Distribution Channel Includes
Countries Covered	North America U.S., Canada, Mexico Europe Germany, United Kingdom, France, Italy, Spain, Nordic Countries, Benelux Union, Rest of Europe Asia-Pacific China, India, Japan, New Zealand, South Korea, Australia, Southeast Asia, Rest of Asia Pacific Latin America Brazil, Argentina, Rest of Latin America Middle East & Africa Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa
Key Market Players	Leading Tier 1 Corporations Prominent Regional Manufacturers Emerging Market Disruptors Technology Integrators & Suppliers *Complete vendor layout of 15+ major players provided in the final report.
Market Opportunities	Market Size and Growth: Quantifying the total addressable market (TAM) and projected growth rates to assess financial viability. Customer Segmentation: Identifying target audience behaviors, pain points, and specific unfulfilled demands. Competitive Landscape: Analyzing existing competitors' strengths, weaknesses, and market share to pinpoint gaps and opportunities. Industry Trends: Mapping technological, regulatory, and economic shifts that create favorable conditions for market entry. Risk Assessment: Evaluating barriers to entry and operational challenges alongside strategic roadmaps for mitigation.
Value Added Data Infosets	In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by our expert team also include in-depth expert analysis, geographically represented company-wise production and capacity, network layouts of distributors and partners, detailed and updated price trend analysis and deficit analysis of supply chain and demand.

Meet the Team

Julie

Author

Julie Jayne is a distinguished multidisciplinary strategist and the Head of Research at Extent Research, where she leverages over a decade of comprehensive experience in the global market intelligence industry. Backed by a robust academic foundation that includes a B.Sc. and an MBA, she perfectly...

Priya M

Reviewed By

With over 14 years of dedicated professional expertise in business-to-business (B2B) intelligence, Priya M stands as a distinguished leader in corporate strategy, revenue growth, and advanced data analysis. Her dynamic career is defined by a relentless focus on mitigating business risks and empowering corporate executives...

Learn more about Priya M

BASIC ATTRIBUTES \| KEY MARKET INSIGHTS
Report Title	Global Therapeutic Radiopharmaceuticals Market
Base Year	2025
Forecast Period	2025 - 2033
Market Size (Base)	USD 1.14 Billion
Projected Size	USD 4.17 Billion
CAGR	17.60%

                            1 Study Coverage
    1.1 Therapeutic Radiopharmaceuticals Product Introduction
    1.2 Market by Type
        1.2.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Type, 2017 VS 2021 VS 2035
        1.2.2 Radium-223
        1.2.3 Lutetium-177
        1.2.4 Iodine-131
        1.2.5 Other
    1.3 Market by Application
        1.3.1 Global Therapeutic Radiopharmaceuticals Market Size Growth Rate by Application, 2017 VS 2021 VS 2035
        1.3.2 Thyroid
        1.3.3 Bone Metastasis
        1.3.4 Lymphoma
        1.3.5 Other
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Therapeutic Radiopharmaceuticals Sales Estimates and Forecasts 2017-2035
    2.2 Global Therapeutic Radiopharmaceuticals Revenue Estimates and Forecasts 2017-2035
    2.3 Global Therapeutic Radiopharmaceuticals Revenue by Region: 2017 VS 2021 VS 2035
    2.4 Global Therapeutic Radiopharmaceuticals Sales by Region
        2.4.1 Global Therapeutic Radiopharmaceuticals Sales by Region (2017-2022)
        2.4.2 Global Sales Therapeutic Radiopharmaceuticals by Region (2023-2035)
    2.5 Global Therapeutic Radiopharmaceuticals Revenue by Region
        2.5.1 Global Therapeutic Radiopharmaceuticals Revenue by Region (2017-2022)
        2.5.2 Global Therapeutic Radiopharmaceuticals Revenue by Region (2023-2035)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Therapeutic Radiopharmaceuticals Sales by Manufacturers
        3.1.1 Global Top Therapeutic Radiopharmaceuticals Manufacturers by Sales (2017-2022)
        3.1.2 Global Therapeutic Radiopharmaceuticals Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Therapeutic Radiopharmaceuticals in 2021
    3.2 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers
        3.2.1 Global Therapeutic Radiopharmaceuticals Revenue by Manufacturers (2017-2022)
        3.2.2 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Therapeutic Radiopharmaceuticals Revenue in 2021
    3.3 Global Therapeutic Radiopharmaceuticals Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Therapeutic Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Therapeutic Radiopharmaceuticals Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Therapeutic Radiopharmaceuticals Sales by Type
        4.1.1 Global Therapeutic Radiopharmaceuticals Historical Sales by Type (2017-2022)
        4.1.2 Global Therapeutic Radiopharmaceuticals Forecasted Sales by Type (2023-2035)
        4.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Type (2017-2035)
    4.2 Global Therapeutic Radiopharmaceuticals Revenue by Type
        4.2.1 Global Therapeutic Radiopharmaceuticals Historical Revenue by Type (2017-2022)
        4.2.2 Global Therapeutic Radiopharmaceuticals Forecasted Revenue by Type (2023-2035)
        4.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Type (2017-2035)
    4.3 Global Therapeutic Radiopharmaceuticals Price by Type
        4.3.1 Global Therapeutic Radiopharmaceuticals Price by Type (2017-2022)
        4.3.2 Global Therapeutic Radiopharmaceuticals Price Forecast by Type (2023-2035)
5 Market Size by Application
    5.1 Global Therapeutic Radiopharmaceuticals Sales by Application
        5.1.1 Global Therapeutic Radiopharmaceuticals Historical Sales by Application (2017-2022)
        5.1.2 Global Therapeutic Radiopharmaceuticals Forecasted Sales by Application (2023-2035)
        5.1.3 Global Therapeutic Radiopharmaceuticals Sales Market Share by Application (2017-2035)
    5.2 Global Therapeutic Radiopharmaceuticals Revenue by Application
        5.2.1 Global Therapeutic Radiopharmaceuticals Historical Revenue by Application (2017-2022)
        5.2.2 Global Therapeutic Radiopharmaceuticals Forecasted Revenue by Application (2023-2035)
        5.2.3 Global Therapeutic Radiopharmaceuticals Revenue Market Share by Application (2017-2035)
    5.3 Global Therapeutic Radiopharmaceuticals Price by Application
        5.3.1 Global Therapeutic Radiopharmaceuticals Price by Application (2017-2022)
        5.3.2 Global Therapeutic Radiopharmaceuticals Price Forecast by Application (2023-2035)
6 North America
    6.1 North America Therapeutic Radiopharmaceuticals Market Size by Type
        6.1.1 North America Therapeutic Radiopharmaceuticals Sales by Type (2017-2035)
        6.1.2 North America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2035)
    6.2 North America Therapeutic Radiopharmaceuticals Market Size by Application
        6.2.1 North America Therapeutic Radiopharmaceuticals Sales by Application (2017-2035)
        6.2.2 North America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2035)
    6.3 North America Therapeutic Radiopharmaceuticals Market Size by Country
        6.3.1 North America Therapeutic Radiopharmaceuticals Sales by Country (2017-2035)
        6.3.2 North America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2035)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Therapeutic Radiopharmaceuticals Market Size by Type
        7.1.1 Europe Therapeutic Radiopharmaceuticals Sales by Type (2017-2035)
        7.1.2 Europe Therapeutic Radiopharmaceuticals Revenue by Type (2017-2035)
    7.2 Europe Therapeutic Radiopharmaceuticals Market Size by Application
        7.2.1 Europe Therapeutic Radiopharmaceuticals Sales by Application (2017-2035)
        7.2.2 Europe Therapeutic Radiopharmaceuticals Revenue by Application (2017-2035)
    7.3 Europe Therapeutic Radiopharmaceuticals Market Size by Country
        7.3.1 Europe Therapeutic Radiopharmaceuticals Sales by Country (2017-2035)
        7.3.2 Europe Therapeutic Radiopharmaceuticals Revenue by Country (2017-2035)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Type
        8.1.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Type (2017-2035)
        8.1.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Type (2017-2035)
    8.2 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Application
        8.2.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Application (2017-2035)
        8.2.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Application (2017-2035)
    8.3 Asia Pacific Therapeutic Radiopharmaceuticals Market Size by Region
        8.3.1 Asia Pacific Therapeutic Radiopharmaceuticals Sales by Region (2017-2035)
        8.3.2 Asia Pacific Therapeutic Radiopharmaceuticals Revenue by Region (2017-2035)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Therapeutic Radiopharmaceuticals Market Size by Type
        9.1.1 Latin America Therapeutic Radiopharmaceuticals Sales by Type (2017-2035)
        9.1.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Type (2017-2035)
    9.2 Latin America Therapeutic Radiopharmaceuticals Market Size by Application
        9.2.1 Latin America Therapeutic Radiopharmaceuticals Sales by Application (2017-2035)
        9.2.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Application (2017-2035)
    9.3 Latin America Therapeutic Radiopharmaceuticals Market Size by Country
        9.3.1 Latin America Therapeutic Radiopharmaceuticals Sales by Country (2017-2035)
        9.3.2 Latin America Therapeutic Radiopharmaceuticals Revenue by Country (2017-2035)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Type
        10.1.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Type (2017-2035)
        10.1.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Type (2017-2035)
    10.2 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Application
        10.2.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Application (2017-2035)
        10.2.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Application (2017-2035)
    10.3 Middle East and Africa Therapeutic Radiopharmaceuticals Market Size by Country
        10.3.1 Middle East and Africa Therapeutic Radiopharmaceuticals Sales by Country (2017-2035)
        10.3.2 Middle East and Africa Therapeutic Radiopharmaceuticals Revenue by Country (2017-2035)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Bayer
        11.1.1 Bayer Corporation Information
        11.1.2 Bayer Overview
        11.1.3 Bayer Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Bayer Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Bayer Recent Developments
    11.2 Novartis
        11.2.1 Novartis Corporation Information
        11.2.2 Novartis Overview
        11.2.3 Novartis Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novartis Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novartis Recent Developments
    11.3 China Isotope & Radiation
        11.3.1 China Isotope & Radiation Corporation Information
        11.3.2 China Isotope & Radiation Overview
        11.3.3 China Isotope & Radiation Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 China Isotope & Radiation Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 China Isotope & Radiation Recent Developments
    11.4 Dongcheng
        11.4.1 Dongcheng Corporation Information
        11.4.2 Dongcheng Overview
        11.4.3 Dongcheng Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Dongcheng Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Dongcheng Recent Developments
    11.5 Q BioMed
        11.5.1 Q BioMed Corporation Information
        11.5.2 Q BioMed Overview
        11.5.3 Q BioMed Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Q BioMed Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Q BioMed Recent Developments
    11.6 Curium Pharmaceuticals
        11.6.1 Curium Pharmaceuticals Corporation Information
        11.6.2 Curium Pharmaceuticals Overview
        11.6.3 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 Curium Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 Curium Pharmaceuticals Recent Developments
    11.7 Jubilant DraxImage
        11.7.1 Jubilant DraxImage Corporation Information
        11.7.2 Jubilant DraxImage Overview
        11.7.3 Jubilant DraxImage Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Jubilant DraxImage Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Jubilant DraxImage Recent Developments
    11.8 Lantheus
        11.8.1 Lantheus Corporation Information
        11.8.2 Lantheus Overview
        11.8.3 Lantheus Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Lantheus Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Lantheus Recent Developments
    11.9 Spectrum Pharmaceuticals
        11.9.1 Spectrum Pharmaceuticals Corporation Information
        11.9.2 Spectrum Pharmaceuticals Overview
        11.9.3 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Spectrum Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Spectrum Pharmaceuticals Recent Developments
    11.10 Progenics Pharmaceuticals
        11.10.1 Progenics Pharmaceuticals Corporation Information
        11.10.2 Progenics Pharmaceuticals Overview
        11.10.3 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Progenics Pharmaceuticals Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Progenics Pharmaceuticals Recent Developments
    11.11 International Isotopes
        11.11.1 International Isotopes Corporation Information
        11.11.2 International Isotopes Overview
        11.11.3 International Isotopes Therapeutic Radiopharmaceuticals Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 International Isotopes Therapeutic Radiopharmaceuticals Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 International Isotopes Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Therapeutic Radiopharmaceuticals Industry Chain Analysis
    12.2 Therapeutic Radiopharmaceuticals Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Therapeutic Radiopharmaceuticals Production Mode & Process
    12.4 Therapeutic Radiopharmaceuticals Sales and Marketing
        12.4.1 Therapeutic Radiopharmaceuticals Sales Channels
        12.4.2 Therapeutic Radiopharmaceuticals Distributors
    12.5 Therapeutic Radiopharmaceuticals Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Therapeutic Radiopharmaceuticals Industry Trends
    13.2 Therapeutic Radiopharmaceuticals Market Drivers
    13.3 Therapeutic Radiopharmaceuticals Market Challenges
    13.4 Therapeutic Radiopharmaceuticals Market Restraints
14 Key Findings in The Global Therapeutic Radiopharmaceuticals Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer                        

Research Methodology

Data collection and base year analysis are done using proprietary data collection modules with large sample sizes. The process includes obtaining market information through extensive secondary sources, paid databases, and verifying data via primary (industry expert) validation.

Our market models include Vendor Positioning Grids, Market Timeline Analysis, Company Market Share Analysis, and Top-Down/Bottom-Up forecasting models. To know more about the research methodology, drop an inquiry to speak to our industry experts.

Speak to Analyst

Global Therapeutic Radiopharmaceuticals Market